Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Neratinib When Administered Concomitantly to Healthy Subjects

The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of neratinib.

Inclusion criteria:

• Healthy men or women (of non childbearing potential)
• Ages 18 to 50 years old.